Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04275934 · ClinicalTrials.gov registry record
Blood Pressure First Medication Therapy Management
A clinical trial of Hypertension and Cardiovascular Diseases, sponsored by American Pharmacists Association Foundation.
- Completed
- Registry status
- 27
- Enrollment target
- 1
- Study location
NCT04275934: Completed study of Hypertension and Cardiovascular Diseases, sponsored by American Pharmacists Association Foundation.
NCT04275934 is a study of Hypertension and Cardiovascular Diseases that has completed, run by American Pharmacists Association Foundation. The registered enrollment target is 27 participants, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04275934, a study of Hypertension and Cardiovascular Diseases, has completed, sponsored by American Pharmacists Association Foundation.
- COMPLETED
- Registry status
- 27 participants
- Enrollment target
- 1
- Study location
Study Summary
The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.
Primary Outcome
Management of Systolic and Diastolic Blood Pressure Measures
Conditions Studied
Interventions
- BEHAVIORAL Health Management; Blood Pressure
Study Locations (1)
Georgia
- Woodstock Pharmaceutical & Compounding Center Inc. - Woodstock
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 27 participants |
| Start Date | 2020-02-06 |
| Est. Completion | 2020-12-31 |
What the finished NCT04275934 record still lists
NCT04275934 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 27 participants, a relatively small participant target, below the 3,507-participant average among 470 other Hypertension trials with a reported enrollment target (99% lower).
The record links to 3 conditions, with Hypertension appearing as the primary indexed condition, and to 1 intervention - of which Health Management; Blood Pressure is the first listed.
NCT04275934 reports a single indexed study location in Georgia.
Frequently Asked Questions
What is clinical trial NCT04275934 about?
NCT04275934 is a clinical study titled "Blood Pressure First Medication Therapy Management". The primary objective of this project is to improve the health status of participants through pharmacist-delivered blood pressure control programs that demonstrate value to employers and justify adoption, sustainability and scalability of these programs.
What is the current status of trial NCT04275934?
This trial is currently completed. The enrollment target is 27 participants. The study started on 2020-02-06. Estimated completion is 2020-12-31.
What conditions does trial NCT04275934 study?
This clinical trial studies the following conditions: Hypertension, Cardiovascular Diseases, Blood Pressure.
What interventions are being tested in trial NCT04275934?
The interventions under investigation include: Health Management; Blood Pressure (BEHAVIORAL).
Who is sponsoring clinical trial NCT04275934?
This trial is sponsored by American Pharmacists Association Foundation, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04275934 being conducted?
This trial has 1 study location across Georgia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hypertension
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04275934's enrollment target sits among peer trials
27 420th of 470 higher than 51 of 470 other Hypertension trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Hypertension trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Ketone Ester And Salt (KEAS) in Older Adults
RECRUITING · NA
-
How a Mediterranean Diet With Potatoes Impacts Heart and Metabolic Health in Adults With Pre-Diabetes
RECRUITING · NA
-
Autonomic Regulation of Blood Pressure in Premature and Early Menopausal Women
RECRUITING
-
Conical Forearm and Cylindrical Upper Arm Non-Invasive Blood Pressure (NIBP) Measurements in Pregnant Patients
RECRUITING · NA
-
Comparing Healthcare Visit Recording and Open Notes to Improve Chronic iLlness Care Experience in Older Adults
RECRUITING · NA
-
Childhood-Onset Essential Hypertension Natural History Study
RECRUITING
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00912041 · 27 participants · NA
BrainGate2: Feasibility Study of an Intracortical Neural Interface System for Persons With Tetraplegia
- NCT02847559 · 27 participants · Phase 2
Optune Delivered Electric Field Therapy and Bevacizumab in Treating Patients With Recurrent or Progressive Grade 2 or 3 Meningioma
- NCT03380195 · 27 participants · NA
Effects of Watermelon Juice on Heart Rate Recovery and Post-exercise Muscle Soreness
- NCT03384238 · 27 participants · Phase 1
Panitumumab-IRDye800 in Patients With Pancreatic Cancer Undergoing Surgery
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI